Company: ARMP
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001558370-25-011235
Chunk: 21

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part II, Item 5O
Chunk 21
---
Item 5. OTHER INFORMATION 

Insider Trading Arrangements

During the three months ended June 30, 2025, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement,” and none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a “non-Rule 10b5-1 trading arrangement” (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).